Accutane Tracking Programs Fail; Women Still Having Risky Pregnancies While Taking Acne Drug
An industry-run program designed to monitor use of the popular acne drug Accutane has failed to lower rates of unplanned pregnancies and reduce the risk of birth defects in women taking the drug, a federal advisory panel was told Thursday.